PATENT CLAIM ANALYSIS

Application Number: 16153052
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["435", "440000"]

Abstract:
This invention relates to the use of CRISPR nucleic acids to screen for essential and non-essential genes and expendable genomic islands in bacteria, archaea, algae and/or yeast, to kill bacteria, archaea, algae and/or yeast, to identify the phenotype of a gene or genes, and/or to screen for reduced genome size and/or a gene deletion in bacteria, archaea, algae and/or yeast.

Claim (Index 16):
The method of  claim 14 , further provided that an exogenous Cascade polypeptide that is operable with the Cas nuclease, and an exogenous nucleic acid construct encoding the Cascade polypeptide are not introduced into the mixed population of bacterial cells.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.89189
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15167727', '15032985', '15160405', '15460962', '15507176']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6677271884612997
- 35 USC 102 Novelty (BERT): 0.6206923992839513
- Combined Prediction Score: 0.6630237095435648
- Mean Citation Score: 471.122638
- Max Citation Score: 734.0977
- Similarity Product: 477.44457368181946

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test